How to Value a Nurse Staffing Company in 2026

Nurse staffing is not general staffing. I need to say that upfront because the most common mistake I see in this space is someone applying general staffing multiples — 0.3-0.5x revenue, 4-6x EBITDA — to a nurse staffing business and getting a number that bears no relationship to what the business would actually sell for. The economics, regulatory environment, buyer pool, and risk profile of placing RNs, LPNs, and CNAs into healthcare facilities are fundamentally different from placing accountants or warehouse workers.

I've advised on dozens of healthcare staffing transactions, and the valuation range is enormous — from 3x EBITDA for a troubled agency with declining margins to 12x+ for a scaled platform with diversified facility contracts and strong compliance. Understanding where your business falls on that spectrum requires looking at the right metrics.

The Post-COVID Rate Normalization

We need to address the elephant in the room. During 2020-2022, travel nurse bill rates exploded to $120-180 per hour in crisis markets, with some ICU assignments exceeding $200/hr. Agencies that had been generating 8-12% EBITDA margins suddenly saw margins balloon to 20-30%. Owners understandably started thinking about exits at peak earnings.

By 2024-2025, the market normalized. Bill rates for travel RN assignments settled back to $55-85/hr depending on specialty and geography. Per diem and local contract rates dropped proportionally. Agencies that had built their cost structures around crisis-era revenue found themselves squeezed.

Here's what this means for valuation in 2026: every serious buyer is going to normalize your earnings. If your trailing twelve months still reflect any residual COVID-era pricing, a buyer will strip it out. They're going to look at your bill rates by facility, compare them to market benchmarks, and build their model on what they believe is sustainable. The businesses that are commanding the best multiples right now are those that have already completed the normalization — their current run rate reflects the real market, and buyers don't need to guess.

If you're still running at elevated rates on legacy contracts that haven't been rebid, be prepared for buyers to haircut your revenue. It's better to renegotiate now, take the hit to your P&L, and go to market with clean, sustainable numbers than to show inflated revenue that sophisticated buyers will immediately discount.

The Metrics That Actually Drive Value

Nurse staffing businesses aren't valued on revenue alone. The healthcare staffing sector has specific operational metrics that determine where you fall on the multiple spectrum.

Active nurse count is the most important number in your business. Not nurses on your roster — nurses who have worked a shift in the last 30 days. A buyer is acquiring your active workforce and the relationships that keep them working through your agency rather than a competitor. An agency with 200 active nurses is a fundamentally different asset than one with 50, even if revenue per nurse is similar. Scale in nurse staffing creates recruiting efficiency, fill rate improvements, and negotiating leverage with facilities.

Facility contract count and concentration is the second critical metric. If 40%+ of your revenue comes from a single hospital system, you have a concentration problem that buyers will price in. I've seen agencies with heavy concentration in one health system get 20-30% lower multiples than comparable agencies with diversified facility relationships. The ideal profile is 20+ active facility contracts with no single facility exceeding 15-20% of revenue.

Bill rate vs. pay rate spread is where the money is. Your gross margin on each placement — the spread between what you bill the facility and what you pay the nurse (plus burden) — determines your profitability. Healthy agencies maintain 25-35% gross margins after burden. Below 20%, you're in commodity territory and vulnerable to any rate pressure from facilities. Above 35%, you either have exceptional MSA terms or you're in a specialty niche (OR nurses, NICU) where supply is constrained.

Credentialing and compliance infrastructure is often overlooked by sellers but closely examined by buyers. Every nurse your agency places must have current state licensure, background checks, drug screening, competency assessments, and facility-specific credentialing. Joint Commission certification — while not required — signals to buyers that your compliance infrastructure is institutional-grade. Agencies with Joint Commission certification consistently command 1-2 multiple turns higher than non-certified agencies of similar size.

State Licensing and Multi-State Operations

Nurse staffing is regulated at the state level, and the licensing requirements vary dramatically. Some states require staffing agency licensure, background check compliance, specific insurance minimums, and regular audits. Others have minimal requirements. Your state licensure portfolio is an asset.

An agency licensed and operating in 15 states is worth more than one operating in 3 states — even at the same revenue — because the buyer is acquiring market access. Obtaining new state licenses takes time (3-12 months depending on the state), and each active license represents a barrier to entry that protects your revenue.

The Nurse Licensure Compact (NLC) has streamlined some of this by allowing nurses with compact-state licenses to practice across member states, but agency licensing requirements are separate from individual nurse licensing. Don't confuse the two. Your agency still needs to be licensed in each state where you place nurses, and that portfolio matters to buyers.

MSA Terms and Contract Quality

Your Master Services Agreements with facilities are the foundation of your business, and buyers will read every one of them during diligence. The specific terms that impact valuation include:

• Termination provisions: 30-day termination clauses are standard but weak. 90-day or longer termination periods, especially with cure provisions, create revenue stability that buyers value.
• Exclusivity or preferred vendor status: If you're the preferred or exclusive staffing provider for a facility, that contract is worth significantly more than a non-exclusive arrangement where you compete against five other agencies for each shift.
• Rate escalation language: MSAs with built-in annual rate adjustments (tied to CPI or a fixed percentage) protect margins. Flat-rate contracts that haven't been adjusted in three years are a margin compression risk.
• Direct hire conversion fees: Facilities that hire your nurses permanently should owe a conversion fee. This is both a revenue source and a retention mechanism. Agencies without conversion fee language are leaving money on the table.

Who's Buying Nurse Staffing Agencies

The buyer landscape for nurse staffing agencies is concentrated among a handful of large platforms and an active PE community.

AMN Healthcare (NYSE: AMN) is the largest healthcare staffing company in the U.S. with roughly $3B in annual revenue. They acquire nurse staffing agencies to expand geographic coverage and add specialty capabilities. AMN typically targets agencies with $20M+ revenue but has done smaller tuck-in deals.

Cross Country Healthcare (NYSE: CCRN) is the second major public acquirer, focused on travel nursing, per diem, and allied health. Aya Healthcare is privately held but has been one of the most aggressive acquirers in recent years, building a platform through both organic growth and acquisitions.

Beyond the large platforms, PE firms have been active in healthcare staffing. The thesis is compelling: fragmented industry, recurring revenue from facility contracts, and demographic tailwinds (aging population, nursing shortages). PE-backed platforms typically target agencies with $5-15M in revenue as add-on acquisitions, paying 5-8x EBITDA for businesses with clean compliance records and diversified facility relationships.

Valuation Ranges in 2026

Based on transactions I've seen and market data, here's where nurse staffing valuations are landing in the current market:

• Small agencies ($1-5M revenue): 0.3-0.6x revenue or 3-5x EBITDA. At this size, you're selling a job more than a business, and buyers price in the key-person risk.
• Mid-size agencies ($5-20M revenue): 0.5-0.9x revenue or 5-8x EBITDA. This is where the market gets competitive, especially if you have 100+ active nurses and 15+ facility contracts.
• Scaled platforms ($20M+ revenue): 0.8-1.5x revenue or 8-12x EBITDA. Multi-state operations, Joint Commission certification, technology-enabled scheduling, and a management team that can operate without the founder.

The spread within each tier is driven primarily by margin quality, nurse retention rates, facility diversification, and compliance infrastructure. Two agencies at $10M in revenue can have a $5M difference in enterprise value based on these factors alone.

The Bottom Line

Nurse staffing valuations in 2026 are post-normalization — the COVID windfall is over, and buyers are underwriting sustainable economics. If your agency has navigated the rate correction, maintained its nurse workforce, diversified its facility relationships, and invested in compliance infrastructure, you're in a strong position. The demographic fundamentals — an aging population, chronic nursing shortages, and facility reliance on supplemental staffing — haven't changed. The agencies that are built for the long term, not the crisis, are the ones commanding premium multiples.